Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
1 Introduction Cardiovascular disease (CVD) encompasses a range of heart and blood vessel disorders that are the leading cause of death worldwide
It is therefore important for GPs to have a thorough understanding of the more common pigmented lesions in childhood and adolescence, and to be able to recognise suspicious features that should prompt further action
Kaku, K., Yamada, Y., Watada, H., Abiko, A., Nishida, T., Zacho, J., & Kiyosue, A
The most common symptom is pain and swelling in the big toe, but it can also affect other joints in the foot, ankle, and knee
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
